These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 29493471)
41. [Non-Hodgkin's lymphomas: principles and application of the Kiel classification]. Lennert K Verh Dtsch Ges Pathol; 1992; 76():1-13. PubMed ID: 1283238 [TBL] [Abstract][Full Text] [Related]
43. Rappaport classification of non-Hodgkin's lymphoma: histologic features and clinical significance. Byrne GE Cancer Treat Rep; 1977 Sep; 61(6):935-44. PubMed ID: 332357 [TBL] [Abstract][Full Text] [Related]
44. Malignant lymphomas in Korea. Chi JG; Kim CW; Cho KJ; Lee SK J Korean Med Sci; 1987 Dec; 2(4):231-7. PubMed ID: 3268180 [TBL] [Abstract][Full Text] [Related]
45. [A new system of diagnosis and classification--malignant lymphoma]. Shirakawa S; Kita K; Ohno T; Miwa H Nihon Rinsho; 1992 Jun; 50(6):1200-8. PubMed ID: 1518135 [TBL] [Abstract][Full Text] [Related]
46. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas. Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334 [TBL] [Abstract][Full Text] [Related]
47. Pattern of malignant lymphomas in Rwanda. Ngendahayo P; Schmauz R Bull Cancer; 1992; 79(11):1087-96. PubMed ID: 1302535 [TBL] [Abstract][Full Text] [Related]
48. Clusterin expression in malignant lymphomas: a survey of 266 cases. Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802 [TBL] [Abstract][Full Text] [Related]
49. [Immunohistochemical in situ demonstration of cytokines in Hodgkin and non-Hodgkin lymphoma]. Müller H; Takeshita M; Krause J; Schuster K; Kikuchi M; Stutte HJ Verh Dtsch Ges Pathol; 1992; 76():164-8. PubMed ID: 1283251 [TBL] [Abstract][Full Text] [Related]
50. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma. Ko YH; Kim CW; Park CS; Jang HK; Lee SS; Kim SH; Ree HJ; Lee JD; Kim SW; Huh JR Cancer; 1998 Aug; 83(4):806-12. PubMed ID: 9708949 [TBL] [Abstract][Full Text] [Related]
51. Chest wall lymphomas: Fine needle aspiration cytodiagnosis and review of the literature. Das DK; Pathan SK; Al-Waheeb SKM; Ali AE; Joneja M; Al-Kanderi MG; John B; Mallik MK Cytopathology; 2017 Oct; 28(5):364-370. PubMed ID: 28730684 [TBL] [Abstract][Full Text] [Related]
53. Hodgkin's and non-Hodgkin's lymphomas occurring in two brothers with Wiskott-Aldrich syndrome and review of the literature. Du S; Scuderi R; Malicki DM; Willert J; Bastian J; Weidner N Pediatr Dev Pathol; 2011; 14(1):64-70. PubMed ID: 20429642 [TBL] [Abstract][Full Text] [Related]
54. Malignant lymphoma in western Ethiopia. Getachew A East Afr Med J; 2001 Aug; 78(8):402-4. PubMed ID: 11921560 [TBL] [Abstract][Full Text] [Related]
55. Malignant lymphomas in Pakistan according to the WHO classification of lymphoid neoplasms. Mushtaq S; Akhtar N; Jamal S; Mamoon N; Khadim T; Sarfaraz T; Waqar A Asian Pac J Cancer Prev; 2008; 9(2):229-32. PubMed ID: 18712964 [TBL] [Abstract][Full Text] [Related]
59. Is fascin really a useful marker in distinguishing between classical Hodgkin's lymphoma and various types of non-Hodgkin's lymphomas in difficult cases? Idrees R; Ahmad Z; Qureshi A; Ahsan A; Pervez S J Clin Pathol; 2010 Jul; 63(7):571-4. PubMed ID: 20591908 [TBL] [Abstract][Full Text] [Related]